genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Caffeine Could Help Fight Obesity
News
Gut Microbiome Changes Correlate with Non-Gut Pain
Tech Exclusives
PROTACs Developed with U. of Dundee Boost Boehringer Ingelheim’s Cancer Pipeline
News
Embryonic microRNA Labeled as Fountain of Youth for Heart Cells
News
CBD as a Next-Gen Antibiotic
Insights
Tech Exclusives
Turning Drug Delivery Inside Out
Insights
Sartorius Takes a Single-Use Approach to Derive Value from Biomanufacturing
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Tech Exclusives
Not If. When: Metabolomics’ Impact in Cancer Treatments May Be Just…
News
Type 1 Diabetes Risk Lower in Infants with Rotavirus Vaccination
A-Lists
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
June 2019 Vol. 39 No. 6
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Tech Exclusives
Turning Drug Delivery Inside Out
News
Gut Microbiome Changes Correlate with Non-Gut Pain
Tech Exclusives
PROTACs Developed with U. of Dundee Boost Boehringer Ingelheim’s Cancer Pipeline
News
CBD as a Next-Gen Antibiotic
Magazine
All
Supplement
Tech Exclusives
Fighting the Dangerous Increase of Multidrug-Resistant Microbes
Tech Exclusives
The Microbiome: Here, There, and Everywhere
Commentary
New Vaccine Expected to Play Major Role in Battle against Malaria
Commentary
Lipidomics Enriches Multiomics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
A Web-Based Informatics Platform for PhysChem/ADME/Tox Property Predictions
GENcast
GENcast: Microbiome Research is More Than Just a Gut Reaction
Upcoming Webinars
Mind the Yap! Single-Cell Transcriptomes Reveal Drivers of Intestinal Regeneration
eBooks
Best Practices with an Agilent Parallel CE System
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Therapeutics
Autoimmune Disease Drugs
Autoimmune Disease Drugs
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Autoimmune Disease Drugs
Merck & Co. Expands Pipeline in Cancer, Fibrosis, Autoimmune Diseases by Acquiring Tilos for Up to $773M
Autoimmune Disease Drugs
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Autoimmune Disease Drugs
Cellular Stress, Not Infection, May Rouse Slumbering MS-Linked Retroviruses
Autoimmune Disease Drugs
Lilly, Avidity to Partner on Immunology Drugs in Up-to-$440M Collaboration
Autoimmune Disease Drugs
Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration
Autoimmune Disease Drugs
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
Autoimmune Disease Drugs
argenx Plans Autoimmune Treatments Using Halozyme’s ENHANZE Drug-Delivery Technology
Autoimmune Disease Drugs
Top 10 GEN News Articles of 2018
Autoimmune Disease Drugs
Lilly, Aduro to Develop STING Pathway Inhibitors for Autoimmune Diseases
Autoimmune Disease Drugs
Microbiome Modeling Reveals How Bacteria Shape Host Fitness
Autoimmune Disease Drugs
New Work Opens Door to Manipulating Aberrant Calcium Signaling in Immune...
Autoimmune Disease Drugs
GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development
Autoimmune Disease Drugs
Merck & Co. Partners with Sutro on Cytokine Derivatives for Cancer,...
Autoimmune Disease Drugs
Pollution and Genes Work Together to Increase Severity of Rheumatoid Arthritis
Autoimmune Disease Drugs
Cell Therapy Developer Rubius Therapeutics Raises $100M More
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug5_2014_56448122_DNAblue_NovelDiagnosticGenomic12114111424-324x160.jpg "GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development")
![Individuals with a particular version of a gene have an increased risk for rheumatoid arthritis and the severity of bone damage. [National Library of Medicine]](https://www.genengnews.com/wp-content/uploads/2018/08/Apr19_2018_NLM_RheumatoidArthritis2477013519-324x160.jpg "Pollution and Genes Work Together to Increase Severity of Rheumatoid Arthritis")
